Live Community Engagement & Referral Workshops

upcoming live workshops

Where: AMA Conference Center, Room 303-304 (1170 Peachtree St Atlanta, GA 30309)
Who: Clinicians, APPs, extended care team members, or community advocates
Why: MASLD impacts an estimated 38% of the global adult population and left undetected/unmanaged can progress to metabolic dysfunction-associated steatohepatitis (MASH), liver cirrhosis, or hepatocellular carcinoma (HCC). Despite this, MASLD remains largely undetected, often only discovered in later stages of the disease. With the rising availability of guidelines-recommended non-invasive diagnostics and emergence of new therapies to slow disease progression, early detection and management of MASLD is critical to reduce risk of adverse liver events and improve overall cardio-renal-metabolic health.
CME Info: Eligible attendees will receive up to 3 AMA PRA Category 1 Credits™

This event is free and open to the public. Support for this event was provided by Novo Nordisk, Inc. via an Independent Medical Education grant.

Where: TBD (coming soon)
Who: Clinicians, APPs, extended care team members, or community advocates
Why: MASLD impacts an estimated 38% of the global adult population and left undetected/unmanaged can progress to metabolic dysfunction-associated steatohepatitis (MASH), liver cirrhosis, or hepatocellular carcinoma (HCC). Despite this, MASLD remains largely undetected, often only discovered in later stages of the disease. With the rising availability of guidelines-recommended non-invasive diagnostics and emergence of new therapies to slow disease progression, early detection and management of MASLD is critical to reduce risk of adverse liver events and improve overall cardio-renal-metabolic health.
CME Info: Eligible attendees will receive up to 3 AMA PRA Category 1 Credits™

This event is free and open to the public. Support for this event was provided by Novo Nordisk, Inc. via an Independent Medical Education grant.